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1. Abstract 
Frontotemporal Lobar Degeneration (FTLD) is a neurodegenerative disease 
associated with different patterns of atrophy of the frontal and temporal lobes of the 
brain. The pathology is characterized by an early onset and mainly by changes in 
behavior and personality, with aphasia and language difficulties. Many studies have 
shown that mutations in some genes could cause FTLD. Among the genes that are 
involved, MAPT mutations are the most common in FTD population. The second 
most common gene is GRN which represents the 5- 10% of mutations in FTLD. GRN is 
located in chromosome 17q21 and encodes for progranulin, which is a secreted 
glycoprotein. Progranulin can be proteolytically cleaved, resulting in small peptides 
called granulins. Progranulin plays a role in multiple biological functions, including 
promoting cell cycle progression and survival, proliferation and migration of several 
cell types, transcriptional repression, embryogenesis and inflammation. It is shown 
that the presence of mutations in GRN results in a reduction of the levels of 
progranulin that is relevant for the onset of FTLD. All the mutations found in the 
coding region of GRN cannot explain the heterogeneous panel of the pathological 
characteristics observed in the disease state. This project aims at studying the 
mechanism of post- transcriptional regulation of GRN gene played by miRNA. 
MicroRNAs are a class of ~22 nt non- conding RNAs that control diverse biological 
functions in animals, plants and unicellular eukaryotes by promoting degradation or 
inhibition of translation of target mRNAs. We investigated the regulation effect of 
several microRNAs on the GRN 3’UTR. We found that miR-659 and miR-608 have the 
strongest regulation effect. Understanding that microRNAs regulate the expression 
of progranulin may pave the way to new diagnostic tools and treatments for FTLD.   
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2. Περίληψη 
Η μετωποκροταφική άνοια (ΜΚΑ) είναι μια νευροεκφυλιστική νόσος  που σχετίζεται 
με διαφορετικά πρότυπα ατροφίας του μετωπικού ή και του κροταφικού λοβού του 
εγκεφάλου. Η παθολογία της νόσου χαρακτηρίζεται από πρώιμη έναρξη και κυρίως 
από αλλαγές στην συμπεριφορά και στην προσωπικότητα του ασθενούς, καθώς και 
από αφασία και γλωσσικές δυσκολίες. Πολλές έρευνες έδειξαν ότι μεταλλάξεις σε 
κάποια γονίδια θα μπορούσαν να προκαλέσουν την μετωποκροταφική άνοια. 
Μεταξύ όλων των γονιδίων που εμπλέκονται στην εμφάνιση της νόσου, οι 
μεταλλάξεις στο γονίδιο MAPT είναι οι πιο συχνές στον πληθυσμό με ΜΚΑ. Το 
δεύτερο πιο συχνό γονίδιο με μεταλλάξεις είναι το γονίδιο GRN που εκφράζει το 5-
10% των μεταλλάξεων στην ΜΚΑ. Το γονίδιο GRN χαρτογραφείται στο χρωμόσωμα 
17q21 και κωδικοποιεί για την προγρανουλίνη, η οποία είναι μια εκκρινόμενη 
γλυκοπρωτεΐνη. Η προγρανουλίνη μπορεί να υποστεί πρωτεολυτική πέψη έχοντας 
ως αποτέλεσμα την δημιουργία μικρών πεπτιδίων που ονομάζονται γρανουλίνες. Η 
προγρανουλίνη διαδραματίζει σημαντικό ρόλο σε διάφορες βιολογικές λειτουργίες, 
συμπεριλαμβανομένου της προώθησης του κυτταρικού κύκλου και της επιβίωσης, 
της εμβρυογένεσης, της φλεγμονής, της διαφοροποίησης και της μετανάστευσης 
διάφορων κυτταρικών τύπων  και της καταστολής της μεταγραφής,. Έχει δειχθεί ότι 
η παρουσία μεταλλάξεων στο γονίδιο GRN συντελεί στην μείωση των επιπέδων της 
προγρανουλίνης, το  οποίο σχετίζεται με την εμφάνιση της ΜΚΑ. Όλες οι 
μεταλλάξεις που έχουν βρεθεί στην κωδική περιοχή του γονιδίου GRN δεν μπορούν 
να εξηγήσουν την ετερογένεια των παθολογικών χαρακτηριστικών που 
παρατηρούνται κατά την διάρκεια της νόσου. Αυτή η εργασία έχει ως στόχο την 
μελέτη του μηχανισμού της μετα-μεταγραφικής τροποποίησης του γονιδίου GRN 
από τα miRNAs. Τα microRNAs είναι μια κατηγορία μη κωδικών RNAs μήκους ~ 22 
νουκλεοτιδίων  τα οποία μπορούν και ελέγχουν διάφορες βιολογικές λειτουργίες σε 
ζώα, φυτά και μονοκύτταρους ευκαρυώτες, προωθώντας την αποικοδόμηση ή την 
αναστολή της μετάφρασης των mRNAs στόχων. Εξετάσαμε την επίδραση κάποιων 
microRNAs στην ρύθμιση της 3’ UTR του γονιδίου GRN και παρατηρήσαμε πως, 
ισχυρότερη επίδραση έχουν τα miR-659 και miR-608. Η κατανόηση ότι τα 
microRNAs ρυθμίζουν την έκφραση της προγρανουλίνης μπορεί να ανοίξει το δρόμο 
για νέα διαγνωστικά εργαλεία και θεραπείες για την ΜΚΑ.  
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3. Introduction 
 
3.1. Frontotemporal Lobar Degeneration 
Frontotemporal Lobar Degeneration (FTLD) is a group of 
neurodegenerative diseases associated with diverse 
patterns of atrophy of the frontal and temporal lobes of the 
brain1. The age of onset is around 50 – 70 years in 75-80% of 
the patients. Frontotemporal Lobar Degeneration is the 
second most common cause of dementia. It includes a large 
group of neurodegenerative disorders characterized mainly by 
changes in behavior and personality, with aphasia and language difficulties2.  
Classification of FTLD patients appears to be complicated due to heterogeneous 
clinical symptoms observed in patients and the overlaps between the 
neurodegenerative mechanisms34. Patients with FTLD can be characterized through 
their clinical symptoms in three groups: a behavioral variant (bvFTD) and two 
language variants (semantic dementia and progressive non fluent aphasia). One 
characterization can be based on the proteinopathies. So, FTLD is divided in the 
group of FTLD-tau, FTLD- FUS, and FTLD-TDP. The Figure 2 presents the classification 
of FTLD. Molecular genetic studies have identified five genes that, when they are 
mutated cause FTLD. The genes that are involved are MAPT, GRN, C9orf72, VCP, 
CHMP2B, TDP- 43 and FUS as observed in figure 2. 
 
Figure 1 MIR findings in FTLD. A, B 
behavioral dementia, C semantic aphasia, D 
PNFA.
41
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MAPT gene is the first significant genetic linkage found in FTLD families. It is located 
at chromosome 17q21 and encode tau protein2. Tau protein in neurons binds to 
axonal microtubules and promotes microtubule stabilization5.  Until now 44 different 
mutations found in MAPT were reported as the cause of the 5-20% of FTLD families6.  
 
A noncoding GGGGCC hexanucleotide repeat has been identified in C9orf727. In 
normal population the size of this hexanucleotide repeat ranges from 3 to 25 units, 
while in patients it is expanded to 60 units and more2. The C9orf72 encodes for an 
ubiquitously expressed protein with unknown function7. 
 
In VCP gene 17 mutations have been found in 41 independent families8. VCP is 
located at chromosome 9p219 and encodes a ubiquitously expressed member of a 
family of ATPases2. The ATPases are associated with a wide variety of cellular 
functions through interactions with adaptor proteins10.  
 
CHMP2B gene is located at chromosome 3p13- 3p12. It is mainly expressed in 
neurons of all major brain regions. It encodes the ESCRT- III complex, the endosomal 
sorting complex required for transport. Its role is in protein degradation pathway.  
Figure 2  Classification of FTLD. 
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TARDBP gene is located at chromosome 1p36.2. It encodes TDP-43, a 414 aminoacid 
protein, and consists of five coding and non-coding exon11. TDP-43 is an RNA- binding 
protein that forms heterogeneous nuclear ribonucleoprotein complexes (hnRNP), 
and plays a role in RNA processing activities of several cellular functions2.  
 
FUS gene is located at chromosome 16p11.2. It encodes FUS, a 526 aminoacid 
protein, and is a member of the hnRNP family. It is implicated in numerous cellular 
processes, including RNA and miRNA processing12. 
 
The second most common cause of FTLD is the presence of mutations in GRN13  and 
we decided to concentrate our attention on its post- transcriptional regulation. GRN 
is located at the chromosome 17q2114. So far 69 different mutations have been 
reported in 231 families2.  
 
3.2. GRN and Progranulin 
GRN is a gene located in chromosome 17q21 and encodes a protein, progranulin. 
GRN is composed of 13 exons15 with the presence of a non- coding exon 1. 
Progranulin is translated as 593 amino acid, 68.5 kDa cysteine- rich protein. It is 
highly glycosylated and secreted as a protein of 88 kDa16. The structure of 
progranulin consist of four stacked β- hairpins in a twisted ladder formation, with the 
help of disulfide bridges forming a central rod-like structure17 . 
 
 
Figure 3 Schematic presentation of chromosome 17
28 
 
Figure 4 Schematic presentation of GRN and the full length of the PGRN. SLPI is the 
secretory leucocytes protease inhibitor, which prevent the cleavage of full length of 
PGRN by elastase.
15 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 10:18:58 EET - 137.108.70.7
9 
 
 The protein is composed of intra-linked granulin peptides. The peptides are being 
subsequently cleaved by protease into individual peptides, each composed of 
cysteine repeat motifs15.   Progranulin (PGRN), also known as granulin –epithelin 
precursor is a protein that plays a role in multiple biological functions, including 
promoting cell cycle progression and  survival18,19,20, proliferation and migration of 
several cell types, transcriptional repression21, embryogenesis22 and   
inflammation18. Studies have shown that progranulin plays a role in wound-healing 
response 13. Progranulin is expressed in many tissues of the body, and in particular in 
epithelial and hematopoietic cells13. Usually progranulin is highly expressed in cells 
with high mitotic rate such as skin epithelium and expressed at low levels in cells 
with low mitotic rate23. Exception of this rule is the epididymal cells which have low 
mitotic rate but high level of progranulin23. Less is known about the effect and the 
role of progranulin in CNS.  
 
The scheme in Figure 5 shows the potentials effects of progranulin in CNS.  As shown 
in the picture, in the case of inflammation PGRN can be cleaved by elastase and 
other type of protease released by microglia. The cleavage of the PGRN can cause 
additional inflammatory events. 
Granulins have an inflammatory role while, the progranulin has an anti- 
inflammatory role with the help of cytokines. On the other hand, astrocytes secrete 
proteins that inhibit the cleavage of PGRN. In case of inflammation the cytokines 
activate the astrocytes and promote the secretion of SLPI. SLPI causes the reduction 
of the cleavage of PGRN which promote the wound healing pathways13. 
Figure 5 Potential role of GRN in CNS10 
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3.3. Progranulin mutations 
 It has been shown that mutations in GRN can cause FTLD – TDP proteinopathy type 
A2.  Clinicopathologies studies have shown that FTLD-TDP type A is most common 
with a percentage of 41- 49% of the cases2,24. Until now, 69 different mutations have 
been identified in 231 families. The mutations include frameshift, nonsense, and 
missense mutations25. Mutations have been identified also in noncoding regions, 
such as promoters, introns, 3’-5’ UTR. The mutations are loss of function, that cause 
a reduction of the protein level and lead to haplo-insufficiency26,27,28. Recent studies 
show a frequency of GRN mutations of 5-10% in FTD population13. 
3.4.  miRNAs : Biogenesis and mechanism 
MicroRNAs are a class of ~22 nt non- conding RNAs that control diverse biological 
functions in animals, plants and unicellular eukaryotes by promoting degradation or 
inhibition of translation of target mRNAs29. They are transcribed in time and tissue 
specific manner.  
Commonly, miRNAs are transcribed from intragenic or intergenic DNA regions by the 
enzyme RNA polymerase II. The transcripts is 1-3kb long and is called pri-miRNA30.  
Subsequently the RNase complex, the RNase III Drosha and its cofactor DGCR8 
perform an endonucleolytic cleavage of the pri-miRNA31. This cleavage produce a 
Figure 6 miRNA Biogenesis42 
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Figure 7 In silico analysis of the base 
pairing of the miR-659 in the 3’ UTR38 
hairpin structure named pre-miRNA with a length of 70-100 nt. Afterwards, the pre-
miRNA is transported from the nucleus to the cytoplasm by Exportin-5. Dicer, 
another RNase III enzyme, helps the maturation of pre-miRNA to a double-stranded 
miRNA of variable length (~20-25nt) in the cytosol 32. The guide strand or mature 
miRNA is joined into RISC, and also the other miRNA called miRNA* can have an 
effect 33,34. In the RISC complex, the miRNA binds to its target mRNA and causes 
target silencing with the help of Argonaute (AGO). The miRNA targeting is specified 
by base- pairing between nucleotides from positions 2 to 8 in the miRNA seed. The 
binding of the miRNA is mainly localized in the 3’-UTR of the target mRNA35, however 
it can also binds the coding and the 5’ UTR regions. When there is a perfect 
complementarity between miRNA and mRNA, the RISC complex induces mRNA 
degradation, whereas imperfect miRNA- mRNA complementarity results in 
translation inhibition35. The complex of imperfect binding (miRNA/mRNA) could be 
translocated to cytoplasmic processing bodies (P-bodies) where untranslated mRNAs 
are stored and degraded 36.  
3.5. miRNAs and progranulin 
As described previously, miRNAs can regulate the translation and stability of the 
mRNAs and as a result the levels of the proteins. Changes in the miRNA expression 
profiles and polymorphisms affect the interaction between miRNAs and their targets 
37. 3 different miRNAs are reported in literature that could regulate the expression 
level of GRN. In 2008 Rosa Rademakers and colleagues discovered that miR-659 can 
be a possible regulator of GRN.  The scientists found that a common genetic variant 
(rs5848), which is located in a binding site region of miR-659 localized in the 3’UTR of 
GRN, increases the risk of developing FTLD-TDP, type A. The presence of the SNP 
creates a stronger binding of the miR-659 that 
cause a strong down-regulation and suppressed 
translation of GRN mRNA38 . 
In silico analysis has shown the pairing of miR-
659 to the predicted binding site in the 3’ UTR of 
GRN, as represented in figure 7. In the (A) 
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scheme is base pairing in the presence of wild type C-allele at the site of the 
common genetic variant (rs5848) and in the (B) scheme is illustrated the base pairing 
in the presence of the SNP (T-allele) at the rs584838. In the presence of the SNP the 
base pairing is stronger between the miR-659 and the 3’ UTR than in the presence of 
the wild type allele. 
Two years later other two microRNAs were found to regulate the expression of the 
human progranulin, miR-29b and miR- 107. It is reported that the miR-29b interacts 
directly with the 3’ UTR of GRN, and regulates its expression39. Although the 3’ UTR 
sequences tend to drift rapidly during  evolution35, the binding sites for miR-29b in 
the 3’ UTR of GRN seem to be  highly conserved  in mammals39.  miR-107 was also 
shown to have a regulative role for GRN40. miR-107 appears to target GRN in the 
open reading frame of the mRNA.  
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4. Aim of the study 
This study is a part of a larger project which has as an aim to develop therapeutic 
strategies for the treatment of Frontotemporal lobar degeneration, due to the fact 
there is no effective treatment for this type of disease. One of the main causes 
associated with the disease is the mutations in GRN. In this project we studied the 
mechanism of post-transcriptional regulation of GRN mediated by microRNAs. 
MicroRNAs have the capability to act at the post-transcriptional level, targeting the 
mRNA. Bioinformatics predictions show that different miRNAs can bind on the 3’UTR 
of GRN, such as miR-615-5p, miR-939, miR-659, and miR-608. The hypothesis we 
tested was a role of the identified miRNAs in post-transcriptional regulation of GRN. 
We transfected in HeLa cell line two plasmids, one for the overexpression of the 
miRNAs of our interest and one that contains the luciferase cDNA followed by the 
GRN 3’ UTR. We observed the effect of miRNAs through Luciferase Assay, ELISA 
Assay and Western Blot. We also monitored the over-expression of the miRNAs 
under study by Real Time PCR. The presence of miRNAs and the subsequent 
recognition of the target site should result in blocking the translation of messenger 
RNA and therefore lower the levels of the expression of Luciferase and the protein 
levels of progranulin. The study was part of my ERASMUS scholarship and was 
conducted at the Laboratory of RNA Biology and Biotechnology of the University of 
Trento, Italy. 
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5. Materials and Methods 
5.1. Plasmids 
Different bioinformatics tools such as PITA algorithm, TargetScan, Targetprofiler 
were used to predict the best putative microRNAs that can bind the 3’ UTR of GRN. 
The microRNAs with the best score in terms of free binding energy and site 
accessibility were selected for the following experiments. Previous work in the 
laboratory leaded to the production of over-expressing vectors of the selected 
microRNAs and different specific reporter vector containing the full length GRN 3’ 
UTR and specific fragments of the GRN 3’ UTR with different binding sites for 
putative microRNAs.  
In figure 8 is presented the full length of GRN 3’ UTR of 304bp, the fragments in 
which the 3’ UTR of GRN was divided and relative positions of the miRNA binding 
sites. The Part I of the GRN 3’UTR of 114 bp was also divided in two smaller 
fragments (fragment A and fragment B).  
 
Figure 8 Schematic representation of miRNAs binding sites on the GRN 3’UTR and its 
division in fragments 
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The pmirGLO Dual Luciferase miRNA Target Expression Vector from Promega  was 
used for cloning of th GRN 3’ UTR and the different fragments. In figure 9 is shown a 
schematic representation of the vector.   
The vector contains the human phosphoglycerate kinase (PGK) promoter which 
provides low translational expression. It contains the firefly luciferase reporter gene 
(luc2) used as the primary reporter to monitor mRNA regulation. The multiple 
cloning site (MCS) located on the 3’ of the firefly luciferase reporter gene (luc2) is 
used to clone the 3’ UTR of interest through the use of specific restriction sites. The 
vector contains a SV40 late poly (A) signal sequence, which is positioned 
downstream of luc2 to provide efficient transcription termination and mRNA 
polyadenylation, and a synthetic poly (A) signal/ transcription stop site. Under the 
control of another promoter called SV40 early enhancer/promoter the vector has the 
humanized Renilla luciferase-neomycin resistance cassette (hRluc-neo), which is used 
as a control reporter for normalization of gene expression. The synthetic poly (A) 
signal acts like a stop site of the transcription. The plasmid contains the Amp gene 
for bacterial selection for amplification of the vector. 
Figure 9 Schematic representation of pmirGLO Vector 
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The miRNA overexpression vector is represented in figure 10.  
The vector contains the Amp gene for bacterial selection. The precursor region of the 
putative microRNAs was cloned under the control of U1 promoter and U1 
terminator. The precursors of the miR-181a, miR-615-5p, miR-939. miR-659, miR-608 
were cloned inside the vector. Through the use of this overexpressing vector we 
have a physiological production of the mature miRNA inside the cell. 
Finally, the AAV- GFP vector was used in order to validate the transfection efficiency 
and efficacy through Operetta®.   
5.2. Eukaryotic cell line  
In our study, in order to examine the mechanism of the post- transcriptional 
regulation in GRN we use HeLa cell lines. 
HeLa cells are derived from human cervix. They are adenocarcinoma cell line. HeLa 
cells are cultured in complete Dulbecco’s Modified Eagle’s Medium (DMEM). The 
complete DMEM contains DMEM with 4.5% g/L Glucose (GIBCO) supplemented with 
10% Fetal Bovine Serum (FBS), 1% Glutamine and 1% Penicillin- Streptomycin. Cells 
Figure 10 psiUx miRNA overexpression Vector
43
 
Figure 11 HeLa cell line 
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are grown and maintained at 37oC with 5% CO2 in a cell incubator. 
5.3. Amplification of the GRN 3’ UTR and sequencing 
We performed RT-PCR in different cell lines, such as HeLa and different types of 
neuroblastoma cell lines, SH-SY5Y, SK-N-BE, Kelly and CHP212 to amplify the full 
length 3’ UTR of GRN of 304bp. The PCR protocol is described below. 
Firstly, we had to perform cDNA synthesis (RevertAid First Strand cDNA synthesis, 
Thermo Scientific) from the RNA extracted from each cell line. 
 
 
 
 
 
 
 
After we performed 
amplification of the cDNA with the protocol below. 
 
 
 
We used the sequencing service of BMR Genomics to check the 3’ UTR of GRN. We 
use 12.2ng of the purified PCR fragment and 3.2μL from each primer. The sequence 
of the primers that we used is:  
Primer Forward: 5’-AATCTAGAGGGACAGTACTGAAG-3’ 
Reagents  
Reaction Buffer (5x) 4μL 
Riboblock  Inhibitor(20u/μL) 1μL 
dNTPS Mix (10mM) 2μL 
Reverse Transcriptase(200u/μL) 1μL 
Final Volume 8μL 
Reagents  
RNA(500ng) 1μL 
Oligo(dt) Primer  1μL 
H2O 10μL 
Final Volume 12μL 
Temperature Time 
65oC 5minutes 
Temperature Time 
42oC 60minutes 
70oC 5minutes 
Reagents  
cDNA 2.5μL 
Buffer (10x) 2.5μL 
dNTPS (10mM) 0.5μL 
Primer Forward (10μM) 0.5μL 
Primer Reverse (10μM) 0.5μL 
Taq RBC (5unit) 0.25μL 
H2O 18.25μL 
Temperature Time 
95oC 1minute 
95oC 1minute 
54oC 50seconds 
72oC 1minute 
95oC 5minutes 
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Primer Reverse: 5’-ATCTAGAGAAAGTGTACAAACTTTATT-3’ 
5.4. Transfection of Eukaryotic cell lines 
5.4.1. Validation of transfection efficiency through Operetta® 
In order to validate the transfection efficiency in HeLa cells we transfected them with 
the AAV-GFP vector. We checked different concentrations of DNA and also different 
amount of cells. The analysis was done by Operetta® and we choose as better result 
the 450ng of total DNA and 75.000 cells. The Operetta® is a microplate reader for 
high content screening. It can acquire, analyze and manage fluorescence and 
brightfield images. Operetta® has a high power Xenon lamp (300W) providing entire 
visible spectrum. It has also, 4 or 8 excitation filters and up to 4 automatically 
exchangeable objective lenses for different fields of view/ resolutions. 
5.4.2. HeLa cells transfection 
Transfection experiments were performed with HeLa cells. The protocol used 
derived from Invitrogen’s manufacturer protocol. 75000 HeLa cells were plated in 
each well of a 24-well format. We co-transfected HeLa with a 3’UTR of GRN reporter 
vector (pmirGLO) and a miRNA overexpressing vector (psiUx) according to the best 
transfection efficiency obtained in the Operetta® analysis. The co-transfection were 
performed with the use of Lipofectamine LTX, a chemical substance that contains 
lipid subunits that can form liposomes in an aqueous environment, which entrap the 
transfection materials, such as DNA plasmids. Lipofectamine is a cationic liposome 
formulation, which complexes with negatively charged nucleic acid molecules to 
Figure 12 Operetta ® 
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allow them to overcome the electrostatic repulsion of the cell membrane. The 
Lipofectamine LTX was combined with Plus Reagent, which is a proprietary reagent 
for pre-complexing DNA that enhances cationic lipid-mediated transfection of DNA in 
eukaryotic cells. A dilution of the Lipofectamine LTX Reagent was performed in Opti-
MEM medium, using a ratio of 1:3 (μg of DNA: μL Lipofectamine LTX) and the Plus 
Reagent ratio was 1:1 to the DNA used. Every transfection experiment was done 
twice in biological duplicates.  
For the protein analysis 375000 cells per well were transfected in a 6-well plate with 
2μg of miRNAs-overexpressing plasmids and Lipofectamine LTX in a ratio 1:3. 
5.5. Analysis of expression 
5.5.1. Dual- Glo Luciferase Assay 
The Dual-Glo® Luciferase Assay is designed to allow high throughput analysis of 
mammalian cells containing genes for firefly and Renilla luciferases grown in 96- or 
384- well plates. The reporter plasmid pmirGLO, contains the firefly luciferase (luc2) 
that is a 61 kDa protein, used as a primary reporter to monitor the regulation of 
different miRNAs on the GRN 3’UTR and Renilla (hRluc) that is a 36 kDa protein used 
for the normalization. These proteins are monomeric and they don’t require post-
translational processing. Their function can act immediately upon translation. 35μL 
of Opti-MEM was added directly to the cells, 
subsequently 35μL of the Dual-Glo® Luciferase 
Assay Reagent (LAR) was added to each well. This reagent induces the cell lysis and 
act as a 
substrate 
for firefly 
luciferase
. 
 
 
Table 1 Composition of RIPA Buffer 
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The plate was wrapped in an aluminium foil to preserve the LAR reagent from light 
and incubated for 15 minutes at room temperature in a shaking Thermoblock. 
Subsequently, 20μL of lysate were loaded in a 384-well plate in technical triplicates 
and used for the measurement of the firefly luminescence on Infinite M200 Tecan 
multiwell plate reader. Then 20μL of the Dual-Glo® Stop & Glo® Reagent diluted in a 
ratio of 1:100 were added directly to the 384-well plate to block the firefly luciferase 
and allow the detection of the Renilla Luciferase, incubated at 25 oC for 30 minutes 
and then measured on the Infinite M200 Tecan multiwell plate reader.  
As represented in figure 14, after the co-transfection with pmirGLO and psiUx in 
HeLa cells if there is no specific miR that binds in the 3’UTR of the interest there is a 
consistent signal of luciferase production. If there is a specific miR that binds to the 
3’ UTR there is a reduction of luciferase activity. 
Figure 13 Diagram of firefly and Renilla luciferase reactions with their respective substrates, beetle 
luciferin and coelenterazine, to yield light. 
Figure 14 Scheme of the luciferase- based reporter system for miRNA- 3’UTR 
interaction 
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5.5.2. Extraction of RNA through Trizol and quantification 
After the co-transfection of HeLa cell line with pmirGLO and psiUx the cells were 
detached from the 24-well using 50μl of trypsin that is then inactivated through the 
use of a DMEM medium containing FBS (Fetal Serum Bovine). All the cells were 
transferred in an eppendorf tube of 1.5ml and centrifuged at 3600rpm, 4oC for 5 
minutes in order to have a pellet of cells. Afterwards the supernatant was removed 
and the cells were kept at -80oC. Trizol Reagent from life technologies was used for 
RNA extraction. The Trizol Reagent is designed to isolate high quality total RNA from 
cells. It is a monophasic solution of phenol, guanidine isothiocyanate and other 
components used to dissolve the cellular components with no damage for the RNA. 
100μL Trizol Reagent were added directly to the pellet of cells and lysis of the cells 
was performed by pipetting up and down. The samples were incubated for 5 minutes 
at room temperature to permit complete dissociation of the nucleoprotein complex. 
After centrifugation of the samples at 12000 x g for 10 minutes at 4°C, the cleaned 
supernatant was transferred to a new tube. 20μL chloroform were added and the 
samples were shaked vigorously by hand or by vortex for 15 seconds. An incubation 
took place for 2-3 minutes at room temperature and a centrifugation of the samples 
at 12000x g for 15 minutes at 4°C. The mixtures separate into a lower red phenol- 
chloroform phase, an interphase and a colorless upper aqueous phase. The RNA 
remains exclusively in the aqueous phase. After centrifugation the aqueous phase 
was removed and placed in a new tube. 50μL isopropanol were added to the 
aqueous phase and the samples were incubated for 10 minutes at room 
temperature. After centrifugation at 12000 x g for 10 minutes at 4°C, the 
supernatant was removed from the tube, leaving only the RNA pellet. Washing of the 
pellet with 100μl of 75% ethanol, the samples were vortex briefly, and then 
centrifuged at 7500 x g for 5 minutes at 4°C. The wash was discarded and the RNA 
pellet was air dried for 5-10 minutes. Finally, the RNA pellet was resuspended in 
RNAse- free water by passing the solution up and down several times though a 
pipette tip. As last step the resuspended RNA was quantified by a NanoDrop™ 1000 
Spectrophotometer. 
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The NanoDrop ™ 1000 Spectrophotometer measures 1μL samples with high accuracy 
and reproducibility. The spectrometer utilizes a patented sample retention 
technology that employs surface tension alone to hold the sample in place. In 
addition, the NanoDrop™ 1000 Spectrophotometer has the capability to measure 
highly concentrated samples without dilution. NanoDrop can measure not only the 
concentration of the plasmids but it can identify the purity of the samples through 
the calculations of the 260/280 nm and 260/230 nm ratios. 
5.5.3. Real- Time PCR for miRNA detection 
In order to detect the mature miRNAs derived from the plasmid of our interest, after 
the transfection of HeLa with miRNA overexpressing vector, we used the TaqMan® 
MicroRNA Assay. The TaqMan® MicroRNA Assay are designed to detect and quantify 
mature microRNAs using real-time PCR instruments. TaqMan® MicroRNA Assays 
offer high- quality quantitative data, has sensitivity and high specificity. It can detect 
and quantify miRNA over more than six logs of dynamic range and also as little as 1 
to 10 ng of total RNA. The assay detects only the mature miRNA, not its precursor, 
with single-base discrimination. Also, it is a fast and simple methodology because the 
two- steps protocol takes less than four hours.  
This method consists in two main steps: the first step is a reverse transcription and 
the second step is a PCR. In the reverse transcription (RT) step, cDNA is reverse 
transcribed from total RNA samples using specific miRNA primers from the TaqMan® 
MicroRNA Assays and reagents from the TaqMan® MicroRNA Reverse Transcription 
Figure 15 NanoDrop ™ 1000 Spectrophotometer 
Figure 16 Reverse transcription step Figure 17 PCR step Figure 18 PCR step 
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Kit.  
In the PCR step, PCR products are amplified from cDNA samples using the TaqMan 
MicroRNA Assay together with the TaqMan® Universal PCR Master Mix. In Table 1 
we report a scheme of the protocol followed for the reverse transcription step. 
   
 
 
  
  
 
 
 
Reagents  RT-PCR Master Mix 
(μL) 
100mM dNTPS (with TTP) 0.15 
Multiscribe™ Reverse 
Transcriptase 50U/μL 
1.00 
10X Reverse Transcription 
Buffer 
1.50 
RNAse Inhibitor 20U/μL 0.19 
Nuclease- free water 4.16 
RNA 2ng/μL 5.00 
Primers 3.00 
Time Temperature 
30min 16°C  
30min 42°C  
5min 85°C  
∞ 4°C 
Reagents RT-PCR Master Mix 
(μL) 
TaqMan MicroRNA 
Assay (20X) 
1.00 
Retrotranscription 
Product 
1.33 
TaqMan 2X Universal 
PCR Master Mix 
10.00 
Nuclease-free water 7.67 
Table 1 RT-PCR Master mix first step 
Table 2 RT-PCR Master Mix second step 
Number Cycles:40 
5min 95oC 
15min 95oC 
60sec 60oC 
∞ 4oC 
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During the second amplification step, it is possible to record the fluorescent signals 
generated by the cleavage of TaqMan probes. The final volume of this reaction step 
is 20μL. The protocol is described in Table 2. Results are analyzed through 2-ΔΔCt 
method that allows to calculate the relative variation of the expression of a target 
gene compared to a control gene. The assumption is that real-time PCR achieves 
optimal amplification efficiencies for both the target and the reference gene. Under 
these conditions it is possible to define Ct as the threshold value of the PCR reaction. 
This value is inversely proportional to the logarithm scale of the starting quantity of 
template cDNA. Moreover, ΔCt is the Ct value for any sample normalized to the 
endogenous housekeeping gene, while ΔΔCt corresponds to the difference between 
the average ΔCt value of the target gene and the average ΔCt for the corresponding 
control gene. Thus, ΔΔCt method provides a sensitive and quantitative measure of 
mRNA levels. 
5.5.4. Protein extraction and quantification 
Transfected HeLa cells derived from a 6-well format, were washed with PBS. Then 
150μL of RIPA Buffer and 1x 
Protease Inhibitors were added.  
RIPA Buffer 
Tris HCl (pH=8) 50mM 
NaCl 150mM 
Protease Inhibitor 1% 
NP-40 1% 
Sodium 
Deoxycholate 
0.5% 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 10:18:58 EET - 137.108.70.7
25 
 
 
 
 
 
 
The lysed cells were maintained under constant stirring for 30 minutes at 4oC. We 
centrifuged the samples at 4oC, 12000rpm for 20 minutes. The supernatant was 
transferred to a new tube and stored at -80 oC.  
SDS 0.1% 
Table 3 Composition of RIPA Buffer 
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The concentrations of the samples were determined with an Infinite M200 Tecan 
multiwell plate reader and the Pierce™ BCA Protein Assay Kit, a detergent-
compatible formulation based on bicinchoninic acid (BCA) for the colorimetric 
detection and quantitation of total protein in the samples. In this method, the Cu+2 is 
reduced to Cu+1 by protein molecules in the alkaline solution with the highly sensitive 
and selective colorimetric detection of the cuprous ion (Cu+)  using a unique reagent 
containing bicinchoninic acid with the formation of an intense purple color. This 
water-soluble complex exhibits a strong absorbance at 562nm that is nearly linear 
with increasing protein concentrations over a broad working range (20-2000μg/mL). 
Protein concentrations generally are determined and reported with reference to 
standards of a common protein such as bovine serum albumin (BSA). A series of 
dilutions of known concentration are prepared from the protein and assayed 
alongside the unknown(s) before the concentration of each unknown is determined 
based on the standard curve.  
 
5.5.5. ELISA  
In order to quantify the endogenous amount of progranulin protein after the 
overexpression of the putative microRNAs in a 6-wells format, we used the 
Progranulin (human) ELISA kit from Adipogen™. This assay is a sandwich Enzyme 
Linked- Immunosorbent Assay (ELISA) for quantitative determination of human 
progranulin in biological fluids. A polyclonal antibody specific for progranulin has 
been precoated onto the 96-well microtiter plate. Standards and samples are 
pipetted into the wells for binding to the coated antibody. After extensive washing 
to remove unbound compounds, progranulin is recognized by the addition of a 
Figure 19 Reaction of BCA protocol 
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biotinylated polyclonal antibody specific for progranulin (Detection Antibody). After 
removal of excess biotinylated antibody, HRP-labeled streptavidin (Detector) is 
added. Following a final washing, peroxidase activity is quantified using the substrate 
3,3’,5,5’- tetramethylbenzidine (TMB). The intensity of the color reaction is 
measured at 450nm after acidification and is directly proportional to the 
concentration of progranulin in the samples. 
 
 
5.5.6. Western Blot 
In order to analyze the endogenous levels of progranulin and also the effect of the 
post-transcriptional regulation of the miRNAs we performed Western Blot assays. 
After the lysis of the samples, the proteins were separated on a polyacrylamide gel 
by electrophoresis. This type of running usually takes the name of SDS- PAGE. The gel 
consists of two parts, the stacking gel and the running gel. 
 Stacking gel (top of the gel) which allows the proteins in a loaded sample to be 
concentrated into a tight band during the first few minutes of electrophoresis 
before entering the resolving portion of a gel. 
 
 
 
 
Figure 20 Schematic presentation of Sandwich Elisa 
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Stacking gel (4%) 
ddH2O 1.95ml 
Tris-HCl 1.5M (pH=6.8) 205μL 
SDS 10% 50μL 
Acrylamide/ Bisacrylamide  
29:1 30% 
350μL 
APS 10% 25μL 
TEMED 2.5μL 
Total 2.5μL 
Table 4 Composition of Stacking gel 
 Running gel (bottom of the gel) which allows the separation of the proteins 
according to their molecular weight. 
 
 
 
 
 
 
The gel is composed of various solutions including SDS, an anionic detergent. It is 
applied to protein sample to linearize proteins and to impart a negative charge to 
linearized proteins. The binding of SDS to the polypeptide chain imparts an even 
distribution of charge per unit mass, thereby resulting in a fractionation by 
approximate size during electrophoresis. APS and TEMED are essential to initiate the 
polymerization. The proteins, after the addition of the loading dye, are denatured at 
95oC for 5minutes. The voltage was kept constant at 90V until the end of the stacking 
gel and then the voltage was set at 180V. 
Running gel (7.5%) 
ddH2O 2.4ml 
Tris-HCl 1.5M (pH=8.8) 1.25ml 
SDS 10% 50μL 
Acrylamide/ Bisacrylamide  
29:1 30% 
1.25ml 
APS 10% 25μL 
TEMED 2.5μL 
Total 5ml 
Table 5 Composition of Running gel 
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 Once the gel was over, we transferred the proteins on a nitrocellulose membrane 
using the system of iBlot (Invitrogen), an instrument for dry transfer that requires 
only 7 minutes at 20V. After the transfer to the membrane, the proteins were 
visualized using Ponceau red. Ponceau is used to prepare a stain for rapid reversible 
detection of protein bands on nitrocellulose membranes. After the membrane was 
washed several times with ddH2O. The membrane was placed for few hours with 5% 
milk in PBS-T at room temperature. Then, after the blocking the membrane was 
incubated overnight at 4oC in a diluted solution (1:5000) of primary rabbit 
monoclonal antibody to GRN (ab108608, Abcam®) in 2% milk in PBS-T. The 
membrane was washed 3 times with PBS-T and then incubated with the secondary 
antibody (926-32211 IRDye® 800CW Goat anti-Rabbit) diluted in milk powder 1% in 
PBS-T. The secondary antibody (IRDye) specifically recognizes the primary antibody 
bound to the target protein. In particular the secondary antibody reacts with the 
light chains of rabbit IgM and IgA. IRDye infrared secondary antibody is optimized for 
high sensitivity and excellent signal to noise performance on LI-COR imaging system. 
LI-COR’s laser technology and 800nm channel were used for the detection of the 
Western Blot image. HPRT was used as a reference gene to normalize the results 
using an anti-HPRT monoclonal rabbit antibody (sc-20975, Santa Cruz 
Biotechnology®) and detected with the same secondary antibody (926-32211 IRDye® 
800CW Goat anti-Rabbit).      
Figure 21 SDS-PAGE 
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6. Results  
6.1. Validation of the transfection efficiency 
In order to validate the transfection efficiency in HeLa cells we used Operetta®. We 
analyzed different amounts of total DNA (300 ng, 400 ng, 500 ng and 600 ng) and 
also different amounts of cells per well (65000 cells, 75000 cells and 85000 cells) in a 
24-well plate. We used the AAV-GFP vector and Lipofectamine LTX to transfect HeLa 
cells, and we checked vitality and the efficiency at 24h and 48h after transfection. 
From the Operetta® analysis the best concentration of total DNA is 450 ng and the 
best amount of cells is 75000 cells for 24-well plate at 24h and 48h. The efficiency at 
24h was around 30% and at 48h was around 65%, as measured calculating the 
number of GFP- positive cells over the total number of cells. The mortality rate 
compare the not treated cells was around 40%. Figures 22-25 show representative 
images from Operetta® at 24h or at 48h post-transfection. 
 
 
Figure 22 Operetta® analysis 24h, 
400ng, 75.000cells 
Figure 23 Operetta® analysis 48h, 
400ng, 75.000cells 
Figure 24 Operetta® analysis 24h, 
500ng, 75.000cells 
Figure 25 Operetta® analysis 48h, 
400ng, 75.000cells 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 10:18:58 EET - 137.108.70.7
31 
 
6.2. Analysis by luciferase reporters of miRNA-mediated 
translational repression 
To validate the predicted interaction of miR-608, miR-615-5p, miR-659 and miR-939 
with the human GRN mRNA 3’UTR, we performed luciferase assay on reporter vector 
in which luciferase cDNA have been fused to either the full length of 3’UTR or 
derivatives thereof. The results from the firefly luciferase assays were normalized on 
the signal of Renilla luciferase. The miRNAs under study were produced by 
transfecting psiUx-based overexpressing vectors. miR-181a was our negative control, 
because it is not predicted to bind on GRN 3’UTR. P-value was calculated using 
unpaired t-test of three biological experiments. One asterisk (*) means P-value less 
than 0.05, two asterisks (**) mean P-value less than 0.01 and three asterisks (***) 
mean P-value less than 0.001.   
6.2.1. RNA extraction and quantification and Real Time PCR analysis of 
miRNA levels 
In order to clarify the effect of the over-expressing plasmid used in the luciferase co-
transfection experiments we extracted the RNA with Trizol and quantified our 
samples through NanoDrop ™ 1000 Spectrophotometer. 
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To measure the levels of specific miRNAs we used the TaqMan® MicroRNA Assay. 
Figures 26 and 27 show the results expressed in 2–ΔCt, a calculation method that 
allows to visualize the relative levels of the different miRNAs, in the different 
samples. ΔCt is the Ct value for any sample normalized to the endogenous 
housekeeping gene. To calculate the fold change of each miRNA upon 
overexpression, compared to basal levels in mock-transfected cells, results were also 
analyzed through 2-ΔΔCt method. ΔΔCt corresponds to the difference between the 
average ΔCt value of the experiment and the average ΔCt for the negative control 
(cells transfected with empty control plasmid). Figures 28 and 29 show the level of 
mature microRNAs expressed as fold change (2-ΔΔCt), compared to the basal 
endogenous levels of microRNAs, averaged on 4 experiments, 24h and 48h after 
transfection, respectively. 
Figure 26 Relative levels of the over-expression of different miRNAs at 24h, with the 
calculation of 2
-ΔCt
. 
Figure 27 Relative levels of the over-expression of different miRNAs at 48h, with the 
calculation of 2-ΔCt. 
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In those graphs light green columns represent the over-expression levels of miR-
181a, miR-615-5p, miR-939, miR-659 and miR-608 at basal conditions and dark green 
columns represent the endogenous levels of miR-181a, miR-615-5p, miR-939, miR-
659 and miR-608 after the transfection of the miRNA over-expression vector at 24h 
and 48h. As we can observe, miR- 181a and miR-939 present at basal condition at 
24h and 48h good expression levels inside the cells and they don’t show a higher 
increase upon the over-expression conditions. On the other hand, miR-615-5p, miR-
659 and miR-608 show low endogenous expression levels in HeLa cells at basal 
condition but an higher increases after the over-expression. 
 
  
 
Figure 28 Fold change of the over-expression for different miRNAs at 24h 
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The graphs show at 24h an increase in the levels of production of the mature miR-
615-5p (7.7-fold), miR-659 (47-fold) and miR-608 (697-fold) compared to the basal 
levels observed in the presence of the empty psiUx plasmid, whereas the over-
expression of miR-939 (2.5-fold) and miR-181a is lower (1.5-fold), since the two 
microRNAs have a higher level of expression at normal/basal condition in HeLa cells.  
Regarding the over-expression reached at 48 hours, it is interesting to note that 
while it is slightly higher for miR-615-5p, compare to 24 hours, for the others miRNAs 
there seems to be no accumulation over time of the microRNAs. In particular, miR-
181a and miR-939 seem to keep the same over-expression levels at 24h and 48h, 
Figure 29 Fold change of the over-expression for different miRNAs at 48h 
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while miR-608 and miR-659 over-expression decreases over time, displaying at 48h 
respectively 1/6 and half of the levels reached at 24 hours.  
6.2.2. miR-608, miR-615-5p, miR-659 and miR-939 interact with GRN full 
length 3’UTR 
After co-transection of HeLa cells with a pmirGLO vector, containing the full length 
GRN 3’UTR, and  psiUx vectors, over-expressing miR-181a, miR-615-5p, miR-939, 
miR-659 or miR-608 we performed luciferase assays in order to investigate putative 
interactions between the microRNAs and the GRN 3’UTR, at 24h and at 48h.  
Figure 30 Results from Luciferase assay 24h full length GRN 3’UTR 
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Figure 30, shows the relative luciferase measured after 24h. All the analyzed miRNAs 
have a down-regulation effect of the luciferase activity, compared to the control 
miR-181a, albeit the luciferase down-regulation measured upon over-expression of 
the miR-608 does not reach significance. Therefore, the four miRNAs might to play a 
role on the post-transcriptional regulation of GRN 3’UTR. The strongest effect on the 
regulation of GRN 3’UTR is observed with the overexpression of miR-659 with a 
reduction of 33.9% compared to the luciferase levels obtained upon over-expression 
of control miR-181a.  
Figure 31 represents luciferase activity 48 hours after transfection of the plasmids. 
For all the miRNAs there is an increased effect of downregulation compared to the 
24h, indicating the active presence of the mature miRNAs after 48h. However the 
variability represented as standard deviation increases with a reduction in the 
significativity of the P-values. The strongest effect on the regulation of GRN 3’UTR is 
again observed with the overexpression of miR-659 with a reduction of 30.7% 
compare to miR-181a. 
Figure 31 Results from Luciferase assay 48h full length GRN 3’UTR 
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6.2.3. miR-608, miR-659 and miR-939 interact with the first 114 bp part 
of GRN 3’UTR 
In order to investigate the specific binding sites of different miRNAs on GRN 3’UTR, 
we used a smaller part of the GRN 3’UTR in HeLa cells. We performed a co-
transfection using the pmirGLO vector, containing the first part of GRN 3’UTR (Part I, 
114bp), and psiUx vectors over-expressing, miR-181a, miR-615-5p, miR-939, miR-659 
or, miR-608. We performed luciferase assay at 24h and at 48h after transfection. 
From the prediction analysis we expect that Part I of GRN 3’UTR could be bound by 
miR-615-5p, miR-939 and miR-608 on two putative binding sites for each and by miR-
659 on one single binding site (see Figure 8).  
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Figure 32, represents the luciferase activity after 24h. Three miRNAs (miR-939, miR-
Figure 32 Results from Luciferase assay 24h Part I of GRN 3’UTR 
Figure 33 Results from Luciferase activity 48h Part I of GRN 3’UTR 
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659, and miR-608) show a significant repression of luciferase activity. The strongest 
effect is observed with the overexpression of miR-939 with a reduction in luciferase 
levels of 21.7% compared to miR-181a levels, whereas miR-615-5p induces a small 
and not significant downregulation of the luciferase.  
Figure 33 illustrates the luciferase activity observed after 48h. As for the full-length 
3’UTR, there is an increased downregulation for miR-659 and miR-608, compared to 
the results obtained at 24h. However, upon over-expression of miR-939, a smaller 
luciferase repression is observed at 48h, compared to 24h.  
The downregulation of luciferase observed in Figure 33 with miR-615-5p reaches a 
reduction of 27.5% compared the negative control with miR-181a. However this 
reduction is not significant due to the high variability observed during the different 
experiments. Taken together, these results might indicate that the effect of miR-615-
5p, seen on the full length 3’UTR at 24h (Figure 30) might be played through the 
third binding site of miR-615-5p, localized on the second part of GRN 3’UTR. 
6.2.4. Does miR-615-5p interact with the first 65nt portion of GRN 
3’UTR? 
In order to better analyze the microRNAs regulation on Part I of GRN 3’UTR, we 
performed a co-transfection experiment in HeLa cells with the pmirGLO vector, 
containing the first 65bp of GRN 3’UTR, dubbed “Fragment A”. Fragment A contains 
only a single binding site for miR-615-5p (see Figure 8) and we did a Luciferase assay 
in order to investigate only its interaction with miR-615-5p, using miR-181a as a 
Figure 34 Results from Luciferase activity 24h Fragment A, Part I GRN 3’UTR 
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negative control. 
In figure 34 are reported the results of the luciferase after 24h. In the presence of 
miR-615-5p there is a small reduction of luciferase of 11.3% compared to the 
negative control. However this graph reports the results from a single experiment 
performed at only 24h. Further analysis should include repetitions of this 
experiment, to be done with the presence of all putative microRNAs under 
investigation, and also at 48h after transfection. 
6.2.5. miR-608, miR-659 and miR-939 interact with portion 60 to 123 nt 
of GRN 3’UTR 
Fragment B, corresponding to nt 60 to 123 of GRN 3’UTR, contains two binding sites 
for miR-939 and miR-608, partially overlapping, one binding site for miR-659 and one 
for miR-615-5p (Figure 8). These interactions were analyzed through co-transfection 
of HeLa cells with the pmirGLO vector, containing the Fragment B, and the psiUx 
vectors over-expressing miR-181a, miR-615-5p, miR-939, miR-659 or miR-608. We 
performed Luciferase assays at 24h and at 48h. 
Figure 35 shows the results after 24h: a small and non-significant downregulation for 
all the putative miRNAs can be observed. 
Figure 35 Results from Luciferase activity 24h Fragment B, Part I GRN 3’UTR 
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The downregulation reported at 24h increases at 48h, as shown in Figure 36. Three 
microRNAs have a significant effect on luciferase levels at 48h (miR-615-5p, miR-939 
and miR-659). As miR-608 and miR-939 have overlapping binding sites, the lack of an 
effect of miR-608 on the luciferase levels might be due to the higher endogenous 
level of expression of miR-939 in HeLa cells compared to miR-608. 
Overall, we would expect that a small fragment such as Fragment B would be less 
affected by the endogenous proteins or miRNAs present inside the cells, compare to 
the full length GRN 3’UTR, therefore allowing to observe a higher extent of effect 
upon over-expression of specific miRNAs. However, we observed a better down-
regulation of luciferase with the use of the full-length GRN 3’UTR. It can be 
speculated that the different folding structures of GRN 3’UTR and its fragments could 
play a role on the dynamics of the miRNA interactions and regulations.  
6.2.6. The putative interaction of miR-615-5p with the 3’ 190-nt portion 
of GRN 3’UTR is not clarified 
The 190 bp-long 3’ part of GRN, dubbed Part II, was analyzed through a Luciferase 
assay in which we co-transfected HeLa cells with the pmirGLO vector, containing 
PartII, and psiUx vectors, overexpressing miR-181a, miR-615-5p, miR-939 or miR-608. 
Part II includes only a predicted binding site for miR-615-5p. 
Figure 36 Results from Luciferase activity 48h, Fragment B Part I GRN 3’UTR 
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Figure 37 illustrates the result of luciferase assays after 24h. Unexpectedly, the strongest 
Figure 37 Results from Luciferase activity 24h Part II of GRN 3’UTR 
Figure 38 Results from Luciferase activity 48h Part II of GRN 3’UTR 
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effect o Part II GRN 3’UTR is observed upon over-expression of miR-659, with a reduction of 
19.5% compare to miR-181a, even without the presence of predicted binding sites for miR-
659 on this part of GRN 3’UTR. However, this graph reports the results from a single 
experiment  performed at 24h and 48h. Further analysis should include repetitions of this 
experiment, in order to understand this down-regulation of luciferase, when over-expression 
of miR-659 took place. 
However, this effect of miR-659 is reduced at 48h, as we can observed from Figure 38. As 
expected the Figure 38 shows a major reduction of luciferase of 23.8% with miR-615-
5p compare the negative control. This results derive from a single experiment with 
two biological duplicate and three technical replicates. Therefore further 
experiments should be performed to confirm and better investigate on the miRNA 
regulation of the Part II of GRN 3’UTR. 
6.3. miR-608 and miR-659 regulate endogenous progranulin 
levels 
6.3.1. ELISA analysis 
In order to analyze the effect of the overexpression of our miRNAs of interest on the 
endogenous progranulin protein level a sandwich Enzyme Linked- Immunosorbent 
Assay (ELISA) for quantitative determination of human progranulin in biological fluids 
10.9% 
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(Adipogen).  
Figure 39 shows the ELISA result 48h after transfection of the miRNA over-expressing 
vectors in HeLa cells. A strong downregulation of progranulin levels were observed 
with miR-608 (-26.4%) and miR-659 (-28%). A small and not significant down-
regulation is also shown in the presence of miR-181a, possibly due to the presence of 
a potential binding site for miR-181a on the coding region of progranulin. These 
results derived from a single experiment with 3 technical replicates and further 
analysis are necessary to confirm these data. 
6.4. Western Blot 
In order to quantify the endogenous amount of protein after the overexpression of 
the putative microRNAs in 6 well format, using HeLa cells, we used Western Blot. For 
the Western Blot we used 20μg of total protein. The next figures show the results 
from Western Blot.  
  
 
miR-659 and miR-608 have the strongest repression effect on the endogenous levels 
of progranulin with a percentage of 33.7 and 25.6, compare to the Empty that 
represent the 100%. Also miR-615 and miR-939 have an effect on the protein level of 
progranulin, albeit smaller. The strong downregulation of progranulin protein in the 
presence of miR-659 and miR-608 was therefore confirmed through two different 
techniques, such as ELISA and Western Blot. 
    Empty  608     659       615     939    181a 
75kDa 
50kDa 
25kDa 
Figure 39 Results of Elisa assay 48h 
Figure 40 Western Blot results 
100%  33.7%    25.6%  85.6%   88.2%    
95.5% 
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6.5. GRN 3’ UTR sequencing  
We performed an RT-PCR to amplify the full length of GRN 3’UTR using RNA 
extracted from HeLa cells and from four different neuroblastoma cell lines (SH-SY5Y, 
SK-N-BE, Kelly and CHP212). In order to investigate the presence of polymorphisms 
in the GRN 3’ UTR, the RT-PCR reactions were subsequently purified and sent for the 
sequencing service of BMR Genomics, as described previously. Interestingly we 
found that three different neuroblastoma cell lines (SK-N-BE, Kelly and CHP212) 
contain in different proportion the allele of the rs5848 SNP reported by Rademarkers 
and collaborators38. Whereas HeLa and SH-SY5Y cell lines present only the wild type 
C allele. The sequencing results for the region of interest that contain the SNP are 
reported in the figures below. As already described, the presence of a SNP creates a 
stronger binding of the miR-659 that lead to a strong down-regulation and a reduced 
translation of GRN mRNA. Therefore in these cell lines we could potentially aspect to 
observe a different regulation of the GRN mRNA after the over-expression of miR-
659, due to the presence or the absence of a common genetic variant localized on 
the binding site region of miR-659. 
 
 
Figure 41 Results from sequencing of HeLa cell line 
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Figure 42 Results from sequencing of SH-SY5Y cell 
line 
Figure 43 Results from sequencing of SK-N-BE cell 
line 
Figure 45 Results from sequencing of Kelly cell 
line 
Figure 44 Results from sequencing of CHP212 cell line 
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7. Discussion and Future Prospective 
Frontotemporal Lobar Degeneration is a neurodegenerative disorder that affects 
behavior, language and motor skills and can be caused by mutations in several genes 
such as GRN. There is not a unique correlation between the mutations found on the 
coding region of GRN and the development of the disease. We decided to investigate 
the regulation of the GRN 3’UTR mediated by miRNAs to find if an altered post- 
transcriptional regulation can be correlated with the pathology. This study is part of 
a larger project which has as an aim to develop therapeutic strategies for the 
treatment of the disease. The first aim of this thesis project was to co-transfected 
the plasmid psiUx and the pGLO vector in HeLa cell line and analyze the miRNAs 
regulation through Luciferase assay. After the different transfection experiments 
with all the fragments we observed that the miR-659 has a strong regulation effect 
on all the fragments and also in the total 3’UTR of GRN. We performed Real Time 
PCR to detect the level of the mature miRNA after the use of the over-expressing 
vector in HeLa cells. We observed a high level of over-expression for the miR-659, 
miR-615-5p and miR-608 that show low levels in basal conditions. Whereas miR-181a 
and miR-939 have a higher endogenous level in HeLa cells and the over-expression 
was not achieved.The second aim of this study was to check if the miRNAs have any 
effect on the endogenous levels of progranulin. This question was checked through  
Elisa Assay and Western Blot. The results from those assays shown that miR-659 and 
miR-608 have a strong regulation effect on the endogenous levels of progranulin. 
Further analysis should be done to validate the effect of miR over-expression on the 
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protein level through Western Blot and ELISA. Also, it would be helpful to use 
mutations site specific to understand better the role of each microRNAs on the 
3’UTR of GRN.  
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